vs
艾伯维（ARGX）与WEIS MARKETS INC（WMK）财务数据对比。点击上方公司名可切换其他公司
艾伯维的季度营收约是WEIS MARKETS INC的1.9倍（$2.5B vs $1.3B），艾伯维净利率更高（35.5% vs 2.5%，领先33.0%），艾伯维同比增速更快（83.2% vs 5.0%），艾伯维自由现金流更多（$322.4M vs $36.4M）
艾伯维是总部位于美国伊利诺伊州北芝加哥的制药企业，研发生产的药物覆盖多种疾病治疗领域，可满足多元临床需求，致力于为全球不同病症的患者提供可靠的治疗方案选择。
魏斯市场（Weis Markets）是美国本土食品零售企业，总部位于宾夕法尼亚州森伯里。目前在宾夕法尼亚、马里兰、纽约、新泽西、西弗吉尼亚、弗吉尼亚、特拉华七个州运营200家门店，员工规模超2.3万人。
ARGX vs WMK — 直观对比
营收规模更大
ARGX
是对方的1.9倍
$1.3B
营收增速更快
ARGX
高出78.2%
5.0%
净利率更高
ARGX
高出33.0%
2.5%
自由现金流更多
ARGX
多$286.0M
$36.4M
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $2.5B | $1.3B |
| 净利润 | $877.2M | $32.0M |
| 毛利率 | 89.5% | 25.3% |
| 营业利润率 | 28.9% | 3.2% |
| 净利率 | 35.5% | 2.5% |
| 营收同比 | 83.2% | 5.0% |
| 净利润同比 | 1.3% | -5.1% |
| 每股收益（稀释后） | $13.25 | $1.27 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ARGXWMK
| Q4 25 | $2.5B | $1.3B | ||
| Q3 25 | — | $1.2B | ||
| Q2 25 | $1.8B | $1.2B | ||
| Q1 25 | — | $1.2B | ||
| Q4 24 | $1.4B | $1.2B | ||
| Q3 24 | — | $1.2B | ||
| Q2 24 | $901.9M | $1.2B | ||
| Q1 24 | — | $1.2B |
净利润ARGXWMK
| Q4 25 | $877.2M | $32.0M | ||
| Q3 25 | — | $16.9M | ||
| Q2 25 | $414.8M | $25.3M | ||
| Q1 25 | — | $19.5M | ||
| Q4 24 | $865.6M | $33.7M | ||
| Q3 24 | — | $24.5M | ||
| Q2 24 | $-32.5M | $25.4M | ||
| Q1 24 | — | $22.4M |
毛利率ARGXWMK
| Q4 25 | 89.5% | 25.3% | ||
| Q3 25 | — | 24.7% | ||
| Q2 25 | 89.2% | 25.2% | ||
| Q1 25 | — | 24.8% | ||
| Q4 24 | 90.2% | 25.4% | ||
| Q3 24 | — | 24.6% | ||
| Q2 24 | 89.4% | 25.1% | ||
| Q1 24 | — | 24.9% |
营业利润率ARGXWMK
| Q4 25 | 28.9% | 3.2% | ||
| Q3 25 | — | 1.7% | ||
| Q2 25 | 19.2% | 2.5% | ||
| Q1 25 | — | 1.8% | ||
| Q4 24 | 8.7% | 3.3% | ||
| Q3 24 | — | 2.3% | ||
| Q2 24 | -15.4% | 2.6% | ||
| Q1 24 | — | 2.2% |
净利率ARGXWMK
| Q4 25 | 35.5% | 2.5% | ||
| Q3 25 | — | 1.4% | ||
| Q2 25 | 23.4% | 2.1% | ||
| Q1 25 | — | 1.6% | ||
| Q4 24 | 64.1% | 2.7% | ||
| Q3 24 | — | 2.1% | ||
| Q2 24 | -3.6% | 2.1% | ||
| Q1 24 | — | 1.9% |
每股收益（稀释后）ARGXWMK
| Q4 25 | $13.25 | $1.27 | ||
| Q3 25 | — | $0.69 | ||
| Q2 25 | $6.32 | $0.96 | ||
| Q1 25 | — | $0.73 | ||
| Q4 24 | $13.33 | $1.25 | ||
| Q3 24 | — | $0.91 | ||
| Q2 24 | $-0.55 | $0.95 | ||
| Q1 24 | — | $0.83 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $3.5B | $214.2M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $7.3B | $1.4B |
| 总资产 | $8.7B | $2.0B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资ARGXWMK
| Q4 25 | $3.5B | $214.2M | ||
| Q3 25 | — | $177.6M | ||
| Q2 25 | $2.1B | $188.8M | ||
| Q1 25 | — | $337.9M | ||
| Q4 24 | $1.5B | $382.3M | ||
| Q3 24 | — | $381.2M | ||
| Q2 24 | $1.4B | $398.7M | ||
| Q1 24 | — | $397.5M |
总债务ARGXWMK
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | $11.0M | — | ||
| Q1 24 | — | — |
股东权益ARGXWMK
| Q4 25 | $7.3B | $1.4B | ||
| Q3 25 | — | $1.3B | ||
| Q2 25 | $6.1B | $1.3B | ||
| Q1 25 | — | $1.4B | ||
| Q4 24 | $5.5B | $1.4B | ||
| Q3 24 | — | $1.4B | ||
| Q2 24 | $4.3B | $1.4B | ||
| Q1 24 | — | $1.4B |
总资产ARGXWMK
| Q4 25 | $8.7B | $2.0B | ||
| Q3 25 | — | $2.0B | ||
| Q2 25 | $7.2B | $1.9B | ||
| Q1 25 | — | $2.1B | ||
| Q4 24 | $6.2B | $2.1B | ||
| Q3 24 | — | $2.1B | ||
| Q2 24 | $4.8B | $2.1B | ||
| Q1 24 | — | $2.0B |
负债/权益比ARGXWMK
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | 0.00× | — | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $323.3M | $86.6M |
| 自由现金流经营现金流 - 资本支出 | $322.4M | $36.4M |
| 自由现金流率自由现金流/营收 | 13.0% | 2.8% |
| 资本支出强度资本支出/营收 | 0.0% | 3.9% |
| 现金转化率经营现金流/净利润 | 0.37× | 2.71× |
| 过去12个月自由现金流最近4个季度 | $594.5M | $4.8M |
8季度趋势，按日历期对齐
经营现金流ARGXWMK
| Q4 25 | $323.3M | $86.6M | ||
| Q3 25 | — | $59.2M | ||
| Q2 25 | $361.8M | $56.6M | ||
| Q1 25 | — | $4.9M | ||
| Q4 24 | $41.9M | $87.1M | ||
| Q3 24 | — | $25.8M | ||
| Q2 24 | $-124.7M | $40.3M | ||
| Q1 24 | — | $34.2M |
自由现金流ARGXWMK
| Q4 25 | $322.4M | $36.4M | ||
| Q3 25 | — | $-4.7M | ||
| Q2 25 | $356.6M | $1.4M | ||
| Q1 25 | — | $-28.3M | ||
| Q4 24 | $40.9M | $33.7M | ||
| Q3 24 | — | $-16.5M | ||
| Q2 24 | $-125.5M | $10.2M | ||
| Q1 24 | — | $-1.3M |
自由现金流率ARGXWMK
| Q4 25 | 13.0% | 2.8% | ||
| Q3 25 | — | -0.4% | ||
| Q2 25 | 20.1% | 0.1% | ||
| Q1 25 | — | -2.4% | ||
| Q4 24 | 3.0% | 2.7% | ||
| Q3 24 | — | -1.4% | ||
| Q2 24 | -13.9% | 0.9% | ||
| Q1 24 | — | -0.1% |
资本支出强度ARGXWMK
| Q4 25 | 0.0% | 3.9% | ||
| Q3 25 | — | 5.1% | ||
| Q2 25 | 0.3% | 4.5% | ||
| Q1 25 | — | 2.8% | ||
| Q4 24 | 0.1% | 4.3% | ||
| Q3 24 | — | 3.6% | ||
| Q2 24 | 0.1% | 2.5% | ||
| Q1 24 | — | 3.0% |
现金转化率ARGXWMK
| Q4 25 | 0.37× | 2.71× | ||
| Q3 25 | — | 3.50× | ||
| Q2 25 | 0.87× | 2.24× | ||
| Q1 25 | — | 0.25× | ||
| Q4 24 | 0.05× | 2.59× | ||
| Q3 24 | — | 1.05× | ||
| Q2 24 | — | 1.58× | ||
| Q1 24 | — | 1.53× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ARGX
暂无分部数据
WMK
| Grocery | $1.0B | 80% |
| Pharmacy | $186.7M | 14% |
| Fuel Product | $66.5M | 5% |
| Services | $5.9M | 0% |
| Manufacturing | $2.2M | 0% |
